- Home
- ADI vs ELV Comparison
ADI vs ELV Comparison
Compare ADI & ELV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADI
- ELV
- Stock Information
- Founded
- ADI 1965
- ELV 1944
- Country
- ADI United States
- ELV United States
- Employees
- ADI N/A
- ELV N/A
- Industry
- ADI Semiconductors
- ELV Medical Specialities
- Sector
- ADI Technology
- ELV Health Care
- Exchange
- ADI Nasdaq
- ELV Nasdaq
- Market Cap
- ADI 88.5B
- ELV 91.2B
- IPO Year
- ADI 1972
- ELV N/A
- Fundamental
- Price
- ADI $213.98
- ELV $383.79
- Analyst Decision
- ADI Buy
- ELV Buy
- Analyst Count
- ADI 22
- ELV 15
- Target Price
- ADI $241.90
- ELV $519.76
- AVG Volume (30 Days)
- ADI 4.5M
- ELV 1.8M
- Earning Date
- ADI 05-22-2025
- ELV 07-16-2025
- Dividend Yield
- ADI 1.85%
- ELV 1.78%
- EPS Growth
- ADI N/A
- ELV N/A
- EPS
- ADI 3.68
- ELV 25.60
- Revenue
- ADI $9,818,656,000.00
- ELV $183,124,000,000.00
- Revenue This Year
- ADI $10.75
- ELV $11.16
- Revenue Next Year
- ADI $13.06
- ELV $7.13
- P/E Ratio
- ADI $58.15
- ELV $14.99
- Revenue Growth
- ADI N/A
- ELV 6.63
- 52 Week Low
- ADI $158.65
- ELV $357.45
- 52 Week High
- ADI $247.10
- ELV $567.26
- Technical
- Relative Strength Index (RSI)
- ADI 54.09
- ELV 42.71
- Support Level
- ADI $206.00
- ELV $368.75
- Resistance Level
- ADI $218.50
- ELV $384.59
- Average True Range (ATR)
- ADI 5.18
- ELV 14.67
- MACD
- ADI -1.25
- ELV -1.18
- Stochastic Oscillator
- ADI 35.00
- ELV 39.44
About ADI Analog Devices Inc.
Analog Devices is a leading analog, mixed-signal, and digital-signal processing chipmaker. The firm has a significant market share lead in converter chips, which are used to translate analog signals to digital and vice versa. The company serves tens of thousands of customers; more than half of its chip sales are to industrial and automotive end markets. ADI's chips are also incorporated into wireless infrastructure equipment.
About ELV Elevance Health Inc.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of December 2024. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.